Management of Prameha (Type 2 Diabetes Mellitus) with Ayurveda Formulations as Adjuvant Therapy: A Case Report
Article Sidebar
Main Article Content
Abstract
Introduction: Prameha, described in Āyurveda as a tridoṣaja and medo-pradoṣaja disorder, shares close clinical correlation with Type 2 Diabetes Mellitus (T2DM). It is characterized by polyuria or turbid urine (prabhūta/avila mūtra) and is associated with unhealthy dietary habits (apathya-sevana), sedentary lifestyle, and hereditary predisposition (sahaja hetu).
Case Information: A 37-year-old woman with a 10-year history of T2DM was receiving conventional therapy comprising high-dose insulin (54 units/day) and oral hypoglycemic agents. Despite ongoing treatment, she had persistent polyuria (bahu-mūtratā), weakness (daurbalya), and burning sensation in the feet (pāda-dāha).
Intervention: An integrative regimen comprising Paṭolakaturohiṇyādi kaṣāya tablets, Triphala guggulu, and Madhumeharī cūrṇa was prescribed alongside dietary and lifestyle modifications, while conventional therapy was continued initially and tapered gradually.
Results: Over five months, HbA1c reduced from 8.5% to 6.1%, fasting blood glucose normalized, symptoms resolved, and insulin was discontinued. Oral hypoglycemic doses were also reduced.
Conclusion: This case demonstrates the potential of Āyurvedic formulations as adjuvant therapy in the integrative management of T2DM, enabling reduction of pharmacological dependence and improvement in quality of life.
Keywords: Prameha, Āyurveda, Type 2 Diabetes Mellitus, Madhumeharī cūrṇa, Triphalā guggulu, Paṭolakaturohiṇyādi kaṣāya
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
This article is published under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
Authors retain copyright of their work and grant the International Journal of Ayurveda360 a non-exclusive license to publish, distribute, and reproduce the work in any medium, provided the original work is properly cited.
The CC BY 4.0 license permits unrestricted use, distribution, and reproduction in any medium, including commercial use, as long as appropriate credit is given to the original author(s) and source.
How to Cite
References
1) Sushruta Samhita, Nidana Sthana, Prameha Nidanam Adhyaya, 6/6. Available from https://niimh.nic.in/ebooks/esushruta (Accessed on 18 July 2025)
2) Caraka Samhita, Nidana sthana, Prameha Nidanam Adhyaya, 4/7. Available from: http://niimh.nic.in/ebooks/ecaraka (Accessed on 18 July 2025).
3) Sushruta Samhita, Sutra Sthana, Doshadhatumalakshayavruddhivigyaneeya Adhyaya, 15/32. Available from https://niimh.nic.in/ebooks/esushruta (Accessed on 19 July 2025)
4) Dalhana on Sushruta Samhita, Nidana Sthana, Prameha Nidanam, 6/4. Available from https://niimh.nic.in/ebooks/esushruta (Accessed on 18 July 2025)
5) Caraka Samhita, Chikitsa sthana, Pramehachikitsitam Adhyaya, 6/4. Available from: http://niimh.nic.in/ebooks/ecaraka (Accessed on 19 July 2025).
6) Sharma H, Chandola HM. Prameha in Ayurveda: correlation with obesity, metabolic syndrome, and diabetes mellitus. Part 1-etiology, classification, and pathogenesis. J Altern Complement Med. 2011 Jun;17(6):491-6. doi: 10.1089/acm.2010.0396. Erratum in: J Altern Complement Med. 2011 Jul;17(7):661. PMID: 21649515.
7) Solis-Herrera C, Triplitt C, Reasner C, et al. Classification of Diabetes Mellitus. [Updated 2018 Feb 24]. In: Feingold KR, Ahmed SF, Anawalt B, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279119/
8) Tsalamandris S, Antonopoulos AS, Oikonomou E, Papamikroulis GA, Vogiatzi G, Papaioannou S, Deftereos S, Tousoulis D. The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives. Eur Cardiol. 2019 Apr;14(1):50-59. doi: 10.15420/ecr.2018.33.1. PMID: 31131037; PMCID: PMC6523054.
9) Ashtangahridaya, Sutrasthana, Shodanadigansangraha Adhyaya, 15/15. Available from https://vedotpatti.in/samhita/Vag/ehrudayam/?mod=read (Accessed on 21 July 2025)
10) Kumar N, Singh S, Manvi, Gupta R. Trichosanthes dioica Roxb.: An overview. Pharmacogn Rev. 2012 Jan;6(11):61-7. doi: 10.4103/0973-7847.95886. PMID: 22654406; PMCID: PMC3358970.
11) Almeleebia TM, Alsayari A, Wahab S. Pharmacological and Clinical Efficacy of Picrorhiza kurroa and Its Secondary Metabolites: A Comprehensive Review. Molecules. 2022 Nov 29;27(23):8316. doi: 10.3390/molecules27238316. PMID: 36500409; PMCID: PMC9738980.
12) Bulle S, Reddyvari H, Nallanchakravarthula V, Vaddi DR. Therapeutic Potential of Pterocarpus santalinus L.: An Update. Pharmacogn Rev. 2016 Jan-Jun;10(19):43-9. doi: 10.4103/0973-7847.176575. PMID: 27041873; PMCID: PMC4791987.
13) Nayak A. Evaluation of Antidiabetic and Lipid-Lowering Effect of Marsdenia tenacissima and Sphaeranthus indicus. Journal of Pharmacology and Toxicology, 2023:18: 10-16.DOI: 10.3923/jpt.2023.10.16 URL: https://scialert.net/abstract/?doi=jpt.2023.10.16
14) Sharma R, Amin H, Ruknuddin G and Prajapati P. Antidiabetic claims of Tinospora cordifolia (Willd.) Miers: Critical appraisal and role in therapy. Asian Pacific Journal of Tropical Biomedicine. 2015. 5. 68-78. 10.1016/S2221-1691(15)30173-8. Available from: https://www.researchgate.net/publication/274713079_Antidiabetic_claims_of_Tinospora_cordifolia_Willd_Miers_Critical_appraisal_and_role_in_therapy
15) Kumari S, Anmol, Bhatt V, Patil S S, Sharma U. Cissampelos pareira L.: A review of its traditional uses, phytochemistry, and pharmacology, Journal of Ethnopharmacology, Volume 274, 2021, 113850, ISSN 0378-8741
16) Yadav Y. ANTI-INFLAMMATORY AND ANTI-MICROBIAL ACTION OF TRIPHALA GUGGULU: A REVIEW. 13. 2022. Available from: https://www.researchgate.net/publication/362153302_ANTI-INFLAMMATORY_AND_ANTI-MICROBIAL_ACTION_OF_TRIPHALA_GUGGULU_A_REVIEW/citation/download
17) Murthy K, Jagadale S, Solunke R.S. et al. Antidiabetic potential of Triphala Guggul - an ayurvedic formulation in alloxan-induced diabetes animal model. International Journal of Research in Pharmaceutical Sciences. 11. 315-322. 10.26452/ijrps. v11i1.1823. Available from:https://www.researchgate.net/publication/338475839_Antidiabetic_potential_of_Triphala_Guggul_-_an_ayurvedic_formulation_in_alloxan-induced_diabetes_animal_model
18) Bairwa VK, Kashyap AK, Meena P, Jain BP. Triphala's characteristics and potential therapeutic uses in modern health. Int J Physiol Pathophysiol Pharmacol. 2025 Apr 25;17(2):19-36. doi: 10.62347/OBSS5026. PMID: 40401115; PMCID: PMC12089839.
19) Tsalamandris S, Antonopoulos AS, Oikonomou E, Papamikroulis GA, Vogiatzi G, Papaioannou S, Deftereos S, Tousoulis D. The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives. Eur Cardiol. 2019 Apr;14(1):50-59. doi: 10.15420/ecr.2018.33.1. PMID: 31131037; PMCID: PMC6523054.
20) Antonio C. New Insights on Oxidative Stress and Diabetic Complications May Lead to a “Causal” Antioxidant Therapy. Diabetes Care 1 May 2003; 26 (5): 1589–1596. https://doi.org/10.2337/diacare.26.5.1589
21) Yadav Y. ANTI-INFLAMMATORY AND ANTI-MICROBIAL ACTION OF TRIPHALA GUGGULU: A REVIEW. 13. 2022. Available from: https://www.researchgate.net/publication/362153302_ANTIINFLAMMATORY_AND_ANTI-MICROBIAL_ACTION_OF_TRIPHALA_GUGGULU_A_REVIEW/citation/download
22) Eingold KR. Dyslipidemia in Patients with Diabetes. [Updated 2023 Dec 4]. In: Feingold KR, Ahmed SF, Anawalt B, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK305900/
23) The Ayurvedic Formulary of India, Department of Ayurveda, Yoga & Naturopathy, Unani, Siddha, and Homeopathy (AYUSH), Ministry of Health and Family Welfare, Government of India, New Delhi, First ed., vol. part III. 2011, p. 141
24) Bhatnagar, S., Yadav, K., & Bhardwaj, S. (2025, March 6). Effect of Madhumehari Churna as an Adjuvant to Insulin Therapy in the management of Type 1 and Type 2 Diabetes Mellitus: Two Case Reports. International Journal of AYUSH Case Reports, 9(1), 20-29. https://doi.org/https://doi.org/10.70805/ija-care.v9i1.686
25)Bhatnagar S, Yadav K, Bhardwaj S, Sharma K, Raghuvanshi M & Veena. Review of Madhumehari Churna: An ayurvedic polyherbal formulation used in management of Diabetes mellitus. Vol.38. 2024.15-23